Ermis, Ekin; Egger, Riccarda; Leiser, Dominic; Anschütz, Lukas; Raabe, Andreas; Abu-Isa, Janine; Manser, Peter; Aebersold, Daniel M.; Wagner, Franca; Herrmann, Evelyn (2021). Assessment of Tumor Volume Dynamics and Outcome After Radiosurgery for the Treatment of Vestibular Schwannoma: A Single-Center Experience. Otology & neurotology, 42(6), e750-e757. Wolters Kluwer 10.1097/MAO.0000000000003056
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Assessment_of_Tumor_Volume_Dynamics_and_Outcome.36.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (876kB) |
OBJECTIVE
To assess the factors affecting early local and audiometric outcomes in vestibular schwannoma (VS) patients treated with stereotactic radiosurgery (SRS).
STUDY DESIGN
A retrospective review of medical records.
SETTING
Tertiary referral center.
PATIENTS
Records of all adult patients who underwent SRS between 2010 and 2016 for the treatment of VS were retrospectively reviewed. Patients treated with microsurgery or multi-fractionation schemes, and those who had neurofibromatosis type 2, were excluded.
INTERVENTION
SRS, tumor volume/size measurements.
MAIN OUTCOME MEASURES
The impact of tumor volume dynamics on the early local and hearing-related outcomes, together with the factors that influence them following SRS, and comparison of different tumor size measurement methods.
RESULTS
From 2010 to 2016, 53 patients underwent single fraction SRS of 12 Gy. Median follow-up time was 32 months (range, 6-79). At the last follow-up, only one patient had clinical progression. Age less than or equal to 65 years (p = 0.04; odds ratio [OR]: 0.17; 95% confidence interval [CI]: 0.03-0.93) and baseline pure-tone average (PTA) level less than or equal to 30 dB (p = 0.03; OR: 0.90; 95% CI: 0.84-0.96) were associated with maintenance of serviceable hearing. On multivariate analysis, PTA remained significant (p = 0.01; OR: 0.04; 95% CI: 0.003-0.45). In patients with a loss of serviceable hearing, the mean volume increase tended to be higher than in the patients whose hearing was maintained. The linear measurement method underestimated, and the A × B × C/2 equation overestimated, the radiological progression compared with 3D-volumetric delineations.
CONCLUSION
During the median observation period of almost 3 years, we reported our early outcome results. Tumor volume increase may have an impact on serviceable hearing loss after SRS. Currently there is no widely accepted method for the evaluation of post-SRS response. Linear measurement and the A × B × C/2 equation produce less reliable estimates of radiological progression compared with 3D-volumetric delineations. Accurate volume measurements with 3D delineations should be considered as part of clinical routine for assessing progression and deciding on salvage therapies.
Actions (login required)
 |
Edit item |